DotBio

• locale

  China

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.dotbio.com

DotBio specializes in next-generation antibody therapies. The company's proprietary DotBody technology platform is based on the concept of modular design, allowing for the creation of multi-functional antibodies, bi- and tri-specific antibodies, antibody-drug conjugates (ADCs), and intracellular antibodies.